Clinical Trial Update: Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the safety and efficacy of CNK-UT009 in difficult-to-treat inflammatory bowel disease, including Crohn's disease and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• CNK-UT009

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Inflamatory Bowel Disease, Crohn Disease (CD) | Phase 1 | Status: NOT_YET_RECRUITING